A perspective analysis: companion diagnostics: an evolving paradigm in 21st century healthcare

Personalized Medicine
Martina KaufmannEdward D Blair

Abstract

Medical history has not wandered far from its original aspirations of being personalized. Diagnostic capability has evolved from the metaphysical to the anatomical to the cellular and ultimately to the molecular level. Now that diseases can be subclassified into categories that indicate the course of disease and in some cases its likely response to treatment, there is a responsibility to act on that information. As more predictive biomarkers become clinically validated and as more targeted therapies become available, single marker companion diagnostics for specific drugs will be replaced by multiplex and multiparameter diagnostics that may be applicable across disease entities preserving sample, time, money and enabling rapid molecular taxonomy. We call this an ensemble relationship model between diagnostics and medicines.

References

Oct 3, 1999·Cancer Metastasis Reviews·P AnkerM Stroun
Mar 30, 2001·The Journal of Biological Chemistry·G E StoicaA Wellstein
Mar 3, 2004·Nature Reviews. Cancer·P Andrew FutrealMichael R Stratton
May 20, 2004·Health Services Research·Berhanu Alemayehu, Kenneth E Warner
Mar 9, 2005·Cancer Research·Hisayuki ShigematsuAdi F Gazdar
Nov 17, 2006·Nature Chemical Biology·Ian Collins, Paul Workman
Mar 21, 2009·Nature Reviews. Drug Discovery·Jerel C DavisPhilip Ma
Apr 16, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jian YuMichael J Comb
May 15, 2009·Clinical Pharmacology and Therapeutics·A D BarkerL J Esserman
Aug 25, 2009·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Sai-Hong Ignatius Ou, Jason A Zell
Oct 20, 2009·European Journal of Pharmacology·Lasse Sommer KristensenLise Lotte Hansen
Dec 22, 2009·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Chen MaoQing Chen
Sep 28, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Robert PirkerUNKNOWN European EGFR Workshop Group
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Aug 25, 2011·Nature Reviews. Clinical Oncology·Nicholas B La Thangue, David J Kerr
Aug 25, 2011·Nature Reviews. Clinical Oncology·Tony S K Mok
Sep 6, 2011·Drug Discovery Today·Edward D Blair, James A Blakemore
Jan 11, 2012·The Pharmacogenomics Journal·J CohenK Manzolillo
Mar 1, 2012·New Biotechnology·Joshua P Cohen
Mar 24, 2012·Molecular Oncology·Swen HoelderPaul Workman
May 16, 2012·Cancer Discovery·Edward S KimWaun K Hong
May 18, 2012·British Journal of Clinical Pharmacology·Rashmi R Shah, Devron R Shah
Jun 1, 2012·Science Translational Medicine·Tim ForshewNitzan Rosenfeld
Jul 12, 2012·Nature Biotechnology·Bissan Al-LazikaniPaul Workman
Jan 2, 2013·Archives of Pathology & Laboratory Medicine·Timothy Craig Allen
Jan 31, 2013·Clinical Pharmacology and Therapeutics·D Gonzalez de CastroP Workman
Feb 13, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tianhong LiDavid R Gandara
Apr 17, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stefan SleijferLillian L Siu
Apr 17, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Levi A Garraway
Sep 21, 2013·Biomarkers in Medicine·Francesca ProperziStefano Fais
Sep 21, 2013·Nature·Philippe L BedardLillian L Siu
Sep 26, 2013·Expert Review of Molecular Diagnostics·Jan Trøst Jørgensen
Nov 21, 2013·The New England Journal of Medicine·Francis S Collins, Margaret A Hamburg
Jan 22, 2014·Nature Reviews. Clinical Oncology·Matthew G KrebsCaroline Dive
Mar 19, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Elizabeth A Mansfield
Mar 19, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Francesco PignattiGuido Rasi
Jul 25, 2014·Nature Reviews. Cancer·Zhao ChenKwok-Kin Wong
Aug 20, 2014·Nature Reviews. Clinical Oncology·Andrew M Intlekofer, Anas Younes
Aug 27, 2014·Frontiers in Oncology·Grzegorz J KorpantyNatasha B Leighl
Sep 3, 2014·Nature Reviews. Clinical Oncology·David J Kerr
Mar 1, 2011·Personalized Medicine·Iain MillerAlain Huriez

❮ Previous
Next ❯

Citations

May 2, 2018·Personalized Medicine·Edward D BlairMieke Keppens

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
PMA
genotyping
biopsies
biosensors

Software Mentioned

CellSearch

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Pharmaceutical Science & Technology Today
R C Rowe
European Journal of Internal Medicine
Chayakrit Krittanawong
© 2022 Meta ULC. All rights reserved